These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 33947331)
1. Tauroursodeoxycholic acid prevents Burkholderia pseudomallei-induced endoplasmic reticulum stress and is protective during melioidosis in mice. Yuan S; Fang Y; Tang M; Hu Z; Rao C; Chen J; Xia Y; Zhang M; Yan J; Tang B; He X; Xie J; Mao X; Li Q BMC Microbiol; 2021 May; 21(1):137. PubMed ID: 33947331 [TBL] [Abstract][Full Text] [Related]
2. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis. Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009 [TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress. Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204 [TBL] [Abstract][Full Text] [Related]
4. Tauroursodeoxycholic acid (TUDCA) enhanced intracytoplasmic sperm injection (ICSI) embryo developmental competence by ameliorating endoplasmic reticulum (ER) stress and inhibiting apoptosis. Deng T; Xie J; Ge H; Liu Q; Song X; Hu L; Meng L; Zhang C J Assist Reprod Genet; 2020 Jan; 37(1):119-126. PubMed ID: 31802346 [TBL] [Abstract][Full Text] [Related]
5. TUDCA attenuates intestinal injury and inhibits endoplasmic reticulum stress-mediated intestinal cell apoptosis in necrotizing enterocolitis. Li P; Fu D; Sheng Q; Yu S; Bao X; Lv Z Int Immunopharmacol; 2019 Sep; 74():105665. PubMed ID: 31254957 [TBL] [Abstract][Full Text] [Related]
6. Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro. Jia Z; He Q; Shan C; Li F Toxicol Lett; 2018 Sep; 294():20-26. PubMed ID: 29751043 [TBL] [Abstract][Full Text] [Related]
7. Tauroursodeoxycholic acid reduces ER stress by regulating of Akt-dependent cellular prion protein. Yoon YM; Lee JH; Yun SP; Han YS; Yun CW; Lee HJ; Noh H; Lee SJ; Han HJ; Lee SH Sci Rep; 2016 Dec; 6():39838. PubMed ID: 28004805 [TBL] [Abstract][Full Text] [Related]
8. Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. Cho EJ; Yoon JH; Kwak MS; Jang ES; Lee JH; Yu SJ; Kim YJ; Kim CY; Lee HS Dig Dis Sci; 2014 Jul; 59(7):1461-74. PubMed ID: 24865256 [TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure. Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671 [TBL] [Abstract][Full Text] [Related]
10. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis. Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237 [TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid attenuates inorganic phosphate-induced osteoblastic differentiation and mineralization in NIH3T3 fibroblasts by inhibiting the ER stress response PERK-eIF2α-ATF4 pathway. Liu F; Cui Y; Ge P; Luan J; Zhou X; Han J Drug Discov Ther; 2015 Feb; 9(1):38-44. PubMed ID: 25788050 [TBL] [Abstract][Full Text] [Related]
13. Tauroursodeoxycholic acid enhances the pre-implantation embryo development by reducing apoptosis in pigs. Kim JS; Song BS; Lee KS; Kim DH; Kim SU; Choo YK; Chang KT; Koo DB Reprod Domest Anim; 2012 Oct; 47(5):791-8. PubMed ID: 22151574 [TBL] [Abstract][Full Text] [Related]
14. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum. Wen Y; Zong S; Liu T; Du P; Li H; Xiao H Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298 [TBL] [Abstract][Full Text] [Related]
15. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation. Shi Z; Xu L; Xie H; Ouyang R; Ke Y; Zhou R; Yung WH BMC Pulm Med; 2020 Apr; 20(1):92. PubMed ID: 32299413 [TBL] [Abstract][Full Text] [Related]
16. Tauroursodeoxycholic acid improves pre-implantation development of porcine SCNT embryo by endoplasmic reticulum stress inhibition. Lin T; Lee JE; Oqani RK; Kim SY; Cho ES; Jeong YD; Baek JJ; Jin DI Reprod Biol; 2016 Dec; 16(4):269-278. PubMed ID: 27765486 [TBL] [Abstract][Full Text] [Related]
17. A fluorescent analogue of tauroursodeoxycholic acid reduces ER stress and is cytoprotective. Gavin J; Quilty F; Majer F; Gilsenan G; Byrne AM; Long A; Radics G; Gilmer JF Bioorg Med Chem Lett; 2016 Nov; 26(21):5369-5372. PubMed ID: 27729186 [TBL] [Abstract][Full Text] [Related]
18. Tauroursodeoxycholic acid prevents ER stress-induced apoptosis and improves cerebral and vascular function in mice subjected to subarachnoid hemorrhage. Chen X; Wang J; Gao X; Wu Y; Gu G; Shi M; Chai Y; Yue S; Zhang J Brain Res; 2020 Jan; 1727():146566. PubMed ID: 31778648 [TBL] [Abstract][Full Text] [Related]
19. Chronic inhibition of endoplasmic reticulum stress and inflammation prevents ischaemia-induced vascular pathology in type II diabetic mice. Amin A; Choi SK; Galan M; Kassan M; Partyka M; Kadowitz P; Henrion D; Trebak M; Belmadani S; Matrougui K J Pathol; 2012 Jun; 227(2):165-74. PubMed ID: 22081301 [TBL] [Abstract][Full Text] [Related]
20. TUDCA-Treated Mesenchymal Stem Cells Protect against ER Stress in the Hippocampus of a Murine Chronic Kidney Disease Model. Lee JH; Yoon YM; Lee SH Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30708974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]